Search Results 61-70 of 17257 for Mycosis

  1. Dermatomyositis - Doctors and departments - Mayo Clinic

    ... Mycosis fungoides, Peripheral T-cell lymphoma. Show more areas of focus for Aaron R. Mangold, M.D.. Amir B. Orandi, M.D.. Pediatric ...

  2. Contact dermatitis - Doctors and departments - Mayo Clinic

    ... Mycosis fungoides. Show more areas of focus for Reese L. Imhof, M.D.. Emma F. Johnson, M.D.. Dermatologist; Dermatopathologist. Rochester ...

  3. Safety and Efficacy of PC945 (Opelconazole) in Combination With Other Antifungal Therapy for the Treatment of Refractory Invasive Pulmonary Aspergillosis (OPERA-T Study) - Mayo Clinic

    Participant has proven or probable IPA according to the modified 2019 European Organization for Research and Treatment of Cancer/ Mycoses Study Group ...

  4. An Investigational Immuno-therapy Safety and Effectiveness Study of Nivolumab in Combination With Brentuximab Vedotin to Treat Non-Hodgkin Lymphomas - Mayo Clinic

    ... mycosis fungoides/sezary syndrome (MF/SS), relapsed/refractory primary mediastinal B lymphoma (PMBL), and relapsed/refractory mediastinal gray zone lymphoma ...

  5. Panobinostat in Treating Patients with Relapsed or Refractory Non-Hodgkin Lymphoma - Mayo Clinic

    mycosis fungoides/Sezary syndrome;; primary effusion lymphoma;; blastic NK-cell lymphoma;; adult T-cell leukemia/lymphoma;; extranodal NK/T-cell lymphoma, nasal ...

  6. Sezary syndrome - Diagnosis and treatment - Mayo Clinic

    Staging and prognosis of mycosis fungoides and Sezary syndrome. https://www.uptodate.com/contents/search. Accessed Dec. 1, 2025. James WD. Cutaneous lymphoid ...

  7. T-cell lymphoma - Diagnosis and treatment - Mayo Clinic

    Clinical Overview: Cutaneous T-cell lymphomas (mycosis fungoides and Sézary syndrome). https://www.clinicalkey.com. Accessed July 9, 2025. Chen JJ, et al ...

  8. Extracorporeal Photopheresis and Mogamulizumab for the Treatment of Erythrodermic Cutaneous T Cell Lymphoma - Mayo Clinic

    Histologically confirmed mycosis fungoides (MF) or Sezary syndrome (SS). Safety lead-in: ≥ stage IIB OR ≥ stage IB-IIA folliculotropic/transformed MF ...

  9. CAR-T Cell Therapy Clinical Trials - Mayo Clinic Research

    The purpose of this trial is to evaluate the antitumor activity of Pembrolizumab in patients with advanced mycosis fungoides (MF) as initial systemic therapy.

  10. Non-Hodgkin lymphoma - Doctors and departments - Mayo Clinic

    ... Mycosis fungoides. Show more areas of focus for Khaled Aziz, M.D., Ph.D. Talha Badar, M.B.B.S., M.D.. Hematologist / Oncologist.